Pharmaceuticals Ultrasector Profund Fund Price Prediction
| PHPSX Fund | USD 22.87 0.38 1.69% |
Oversold Vs Overbought
40
Oversold | Overbought |
Using Pharmaceuticals Ultrasector hype-based prediction, you can estimate the value of Pharmaceuticals Ultrasector Profund from the perspective of Pharmaceuticals Ultrasector response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Pharmaceuticals Ultrasector to buy its mutual fund at a price that has no basis in reality. In that case, they are not buying Pharmaceuticals because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell mutual funds at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Pharmaceuticals Ultrasector after-hype prediction price | USD 25.07 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as fund price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Pharmaceuticals |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pharmaceuticals Ultrasector's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pharmaceuticals Ultrasector After-Hype Price Prediction Density Analysis
As far as predicting the price of Pharmaceuticals Ultrasector at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pharmaceuticals Ultrasector or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Mutual Fund prices, such as prices of Pharmaceuticals Ultrasector, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pharmaceuticals Ultrasector Estimiated After-Hype Price Volatility
In the context of predicting Pharmaceuticals Ultrasector's mutual fund value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pharmaceuticals Ultrasector's historical news coverage. Pharmaceuticals Ultrasector's after-hype downside and upside margins for the prediction period are 20.58 and 26.65, respectively. We have considered Pharmaceuticals Ultrasector's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pharmaceuticals Ultrasector is very steady at this time. Analysis and calculation of next after-hype price of Pharmaceuticals Ultrasector is based on 3 months time horizon.
Pharmaceuticals Ultrasector Mutual Fund Price Prediction Analysis
Have you ever been surprised when a price of a Mutual Fund such as Pharmaceuticals Ultrasector is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pharmaceuticals Ultrasector backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Fund price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pharmaceuticals Ultrasector, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.12 | 1.58 | 2.20 | 0.01 | 1 Events / Month | 0 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
22.87 | 25.07 | 9.62 |
|
Pharmaceuticals Ultrasector Hype Timeline
Pharmaceuticals Ultrasector is at this time traded for 22.87. The entity has historical hype elasticity of 2.2, and average elasticity to hype of competition of -0.01. Pharmaceuticals is projected to increase in value after the next headline, with the price projected to jump to 25.07 or above. The average volatility of media hype impact on the company the price is about 8.61%. The price jump on the next news is projected to be 9.62%, whereas the daily expected return is at this time at 0.12%. The volatility of related hype on Pharmaceuticals Ultrasector is about 1717.39%, with the expected price after the next announcement by competition of 22.86. Pharmaceuticals Ultrasector's management efficiency ratios could be used to measure how well Pharmaceuticals Ultrasector manages its routine affairs as well as how well it operates its assets and liabilities. Assuming the 90 days horizon the next projected press release will be very soon. Check out Pharmaceuticals Ultrasector Basic Forecasting Models to cross-verify your projections.Pharmaceuticals Ultrasector Related Hype Analysis
Having access to credible news sources related to Pharmaceuticals Ultrasector's direct competition is more important than ever and may enhance your ability to predict Pharmaceuticals Ultrasector's future price movements. Getting to know how Pharmaceuticals Ultrasector's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pharmaceuticals Ultrasector may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| SRPIX | Short Real Estate | 0.00 | 0 per month | 0.00 | (0.21) | 1.26 | (1.27) | 4.28 | |
| SRPSX | Short Real Estate | 0.00 | 0 per month | 0.00 | (0.22) | 1.33 | (1.32) | 4.27 | |
| UIPIX | Ultrashort Mid Cap Profund | 0.00 | 0 per month | 0.00 | (0.20) | 2.46 | (3.33) | 13.58 | |
| UIPSX | Ultrashort Mid Cap Profund | 0.00 | 0 per month | 0.00 | (0.20) | 2.46 | (3.32) | 13.58 | |
| TEPIX | Technology Ultrasector Profund | 0.00 | 0 per month | 2.16 | (0.01) | 2.84 | (3.72) | 9.83 | |
| TEPSX | Technology Ultrasector Profund | 0.00 | 0 per month | 2.16 | (0.01) | 2.81 | (3.74) | 9.85 | |
| LGPIX | Large Cap Growth Profund | (0.92) | 1 per month | 0.96 | (0.01) | 1.55 | (2.04) | 5.24 | |
| LGPSX | Profunds Large Cap Growth | 0.00 | 0 per month | 0.96 | (0.01) | 1.55 | (2.04) | 5.23 | |
| BRPIX | Bear Profund Bear | 0.00 | 0 per month | 0.00 | (0.29) | 1.31 | (1.12) | 4.80 | |
| BRPSX | Bear Profund Bear | 0.00 | 0 per month | 0.00 | (0.30) | 1.27 | (1.09) | 4.62 |
Pharmaceuticals Ultrasector Additional Predictive Modules
Most predictive techniques to examine Pharmaceuticals price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pharmaceuticals using various technical indicators. When you analyze Pharmaceuticals charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Pharmaceuticals Ultrasector Predictive Indicators
The successful prediction of Pharmaceuticals Ultrasector stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pharmaceuticals Ultrasector Profund, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pharmaceuticals Ultrasector based on analysis of Pharmaceuticals Ultrasector hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pharmaceuticals Ultrasector's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pharmaceuticals Ultrasector's related companies.
Story Coverage note for Pharmaceuticals Ultrasector
The number of cover stories for Pharmaceuticals Ultrasector depends on current market conditions and Pharmaceuticals Ultrasector's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pharmaceuticals Ultrasector is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pharmaceuticals Ultrasector's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Other Information on Investing in Pharmaceuticals Mutual Fund
Pharmaceuticals Ultrasector financial ratios help investors to determine whether Pharmaceuticals Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmaceuticals with respect to the benefits of owning Pharmaceuticals Ultrasector security.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |